埃普斯坦-巴尔病毒相关的急性传播性脑膜炎成功用Rituximab治疗:一个病例报告
Seoyeon Kim1, Seon-Jae Ahn1,2, Kon Chu1,3
1Department of Neurology, Seoul National University Hospital, Seoul, Korea.
Encephalitis (Seoul, Korea)
|July 20, 2023
概括
急性扩散性脑膜炎 (ADEM) 是一种罕见的炎症性脑疾病. 这项案例研究表明,在患有ADEM的患者中,Epstein-Barr病毒感染后,使用rituximab免疫疗法成功恢复.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 急性扩散性脑膜炎 (ADEM) 是中枢神经系统的炎症性脱髓性疾病.
- ADEM通常表现为多焦点神经症状和脑病变.
- 目前的治疗方法包括皮质类固醇,免疫球蛋白或用于耐火病例的血酶.
研究的目的:
- 在埃普斯坦-巴尔病毒 (EBV) 感染后呈现ADEM病例.
- 为了突出在耐火ADEM病例中成功使用Rituximab作为免疫疗法.
- 讨论ADEM的治疗选择,特别是与EBV相关的病例.
主要方法:
- 案例报告的呈现方式.
- 对临床表现,MRI发现和治疗过程的审查.
- 提供免疫疗法,包括Rituximab.
主要成果:
- 患者在埃普斯坦-巴尔病毒感染后发展了ADEM.
- 患者实现了完全的临床康复.
- 用免疫疗法治疗,包括rituximab是有效的.
结论:
- 利图西马布可以成为ADEM患者的有效治疗选择,特别是那些对其他免疫调节剂耐药的患者.
- 在EBV感染后的ADEM可以通过适当的免疫疗法获得良好的结果.
- 这一案例凸显了瑞图西马布在治疗严重或耐火性ADEM方面的潜在作用.
相关概念视频
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...